Account

Compounding Pharmacist Triad

RRM Academy Dr. Naomi Whittaker, MD
By RRM Academy Reviewed by Dr. Naomi Whittaker, MD, Board-Certified OBGYN, MIGS, NFPMC, FCI

The compounding pharmacist collaboration in NaProTechnology is a structured clinical relationship connecting three roles: the NaProTechnology-trained physician, the FertilityCare practitioner, and a licensed compounding pharmacist who prepares individualized isomolecular hormone formulations. Dr. Thomas W. Hilgers formalized this clinical structure as part of NaProTechnology, not as an ancillary arrangement but as an integral component of the medical care model.1

Many isomolecular hormone preparations used in NaProTechnology protocols are not available in standard commercial formulations. A compounding pharmacist who understands the clinical rationale behind cycle-timed hormone protocols, the individualized nature of the prescribing, and the coordination required with the treating physician is not interchangeable with a general dispensing pharmacist. The pharmacist compounds to physician specification; prescribing decisions remain with the physician, informed by the patient's charting data and clinical context.

The FertilityCare practitioner's role in this collaboration is to provide the detailed cycle charting that informs clinical decision-making. Cycle data, including mucus observations and biomarker correlates, guides the physician's assessment of hormonal state and timing. The NaProTechnology Medical Consultant integrates this information with laboratory results before any preparation is prescribed or compounded.

Hilgers' design treats the compounding pharmacist as a clinical collaborator rather than a vendor. The relationship is coordinated and ongoing: formulations may be adjusted based on follow-up assessment, and the pharmacist is expected to understand the framework well enough to support those adjustments accurately. This approach reflects NaProTechnology's broader principle that restorative hormone support requires individualized preparation, not one-size-fits-all commercial dispensing. and cooperative estrogen replacement.

Cited in this entry

  1. Hilgers TW. The Medical and Surgical Practice of NaProTECHNOLOGY. Pope Paul VI Institute Press; 2004. The Medical and Surgical Practice of NaProTECHNOLOGY. https://rrmacademy.org/library/the-medical-surgical-practice-of-naprotechnology-rectiyuppdjrktphh/

This content is for educational purposes only and does not constitute medical advice. Consult an RRM clinician or healthcare provider for guidance specific to your situation.